Jamieson Wellness Inc. (TSE:JWEL) Given Average Rating of "Hold" by Brokerages

Key Points

• Analyst consensus is “Hold”: Four of six brokerages rate Jamieson Wellness shares Hold, while two recommend Buy. The average 12-month price target is C$46.43.
• Several firms recently downgraded the stock to Hold or equivalent, although most raised their price targets to approximately C$45.75–C$49.00.
• JWEL shares rose 0.3% to C$45.60, near their 12-month high, while the company reported C$0.46 quarterly EPS and maintains a quarterly dividend of C$0.23, equivalent to a 2.0% annual yield.

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) has earned an average recommendation of "Hold" from the six research firms that are currently covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is C$46.43.

JWEL has been the topic of a number of research analyst reports. Royal Bank Of Canada cut shares of Jamieson Wellness from an "outperform" rating to a "sector perform" rating and cut their price objective for the stock from C$46.00 to C$45.75 in a report on Monday. TD downgraded shares of Jamieson Wellness from a "buy" rating to a "hold" rating and increased their target price for the company from C$48.00 to C$49.00 in a research report on Monday. Canadian Imperial Bank of Commerce lowered shares of Jamieson Wellness from an "outperformer" rating to a "tender" rating and lifted their price target for the stock from C$44.00 to C$45.75 in a research note on Friday. Stifel Nicolaus cut shares of Jamieson Wellness from a "buy" rating to a "hold" rating and boosted their price target for the company from C$45.00 to C$45.75 in a research report on Friday. Finally, Canaccord Genuity Group downgraded shares of Jamieson Wellness from a "buy" rating to a "hold" rating and upped their price objective for the company from C$44.50 to C$45.75 in a research note on Monday.

Jamieson Wellness Stock Up 0.3%

Shares of JWEL traded up C$0.12 during mid-day trading on Monday, reaching C$45.60. The company's stock had a trading volume of 407,744 shares, compared to its average volume of 100,600. The company has a debt-to-equity ratio of 93.69, a current ratio of 3.41 and a quick ratio of 1.08. Jamieson Wellness has a 12-month low of C$32.54 and a 12-month high of C$45.67. The stock has a market cap of C$1.89 billion, a PE ratio of 26.36 and a beta of 1.48. The company's 50 day moving average is C$39.62 and its 200 day moving average is C$36.77.

Jamieson Wellness (TSE:JWEL - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported C$0.46 earnings per share for the quarter. The firm had revenue of C$233.84 million during the quarter. Jamieson Wellness had a return on equity of 15.93% and a net margin of 8.92%. Equities analysts anticipate that Jamieson Wellness will post 2.1438892 EPS for the current fiscal year.

Jamieson Wellness Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 15th were given a $0.23 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.0%. Jamieson Wellness's dividend payout ratio is 52.02%.

About Jamieson Wellness

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source